We hypothesize that low MT1-MMP-to-LRP-1 ratios or MT1-MMP inhibition would ultimately favor LRP-1-mediated internalization of An2–drug conjugates in gliomas. The gene discussed is MMP14; the disease is central nervous system cancer.